Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1997-06-19
1999-07-27
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514824, A61K 3156
Patent
active
059290625
ABSTRACT:
A composition useful to inhibit cholesterol absorption from the diet is provided. The composition comprises a pharmaceutically acceptable combination of one or more oxysterols and a suitable carrier. The present oxysterol composition can be used therapeutically, prescribed to individuals who are required to reduce cholesterol intake. Alternatively, the composition can used as a dietary supplement by any individual desiring to moderate cholesterol intake.
REFERENCES:
patent: 5244887 (1993-09-01), Straub
patent: 5502045 (1996-03-01), Miettinen et al.
Folch et al., "A Simple Method for the Isolation and Purification of Total Lipides from Animal Tissues", J. Biol. Chem., 1957, 226, 497-509.
Kelley et al., "Effect of Pectin, Gum Arabic and Agar on Cholesterol Absorption, Synthesis, and Turnover in Rats", J. Nutrition, 1978, 108, 630-639.
CA 89:71635, Erickson et al, 1978.
CA 89:186088, Kitame et al, 1978.
Jordan Kimberly
University of Western Ontario
LandOfFree
Oxysterol inhibition of dietary cholesterol uptake does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxysterol inhibition of dietary cholesterol uptake, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxysterol inhibition of dietary cholesterol uptake will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-878905